Report Detail

Request for Sample of this report

Medical Devices & Consumables China Tumor Biomarker Test Market Report 2018

  • RnM3249926
    • |
  • 03 April, 2019
    • |
  • Global
    • |
  • 113 Pages
    • |
  • XYZResearch
    • |
  • Medical Devices & Consumables

Geographically, this report split China into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Tumor Biomarker Test for these regions, from 2012 to 2023 (forecast), including
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China

China Tumor Biomarker Test market competition by top manufacturers/players, with Tumor Biomarker Test sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Abbott Laboratories, Inc.
Agilent Technologies
AstraZeneca
Becton Dickinson & Co.
Biocept Inc.
Cancer Genetics Inc.
Danaher Corporation
Foundation Medicine Inc.
Illumina Inc.
LabCorp Of America Holdings
Luminex Corporation
Myriad Genetics Inc.
NanoString Technologies Inc.

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Prostate Specific Antigen Tests
CTC Tests
Alpha-Fetoprotein (AFP) Tests
CA Test
HER2 Tests
BRCA Test
Anaplastic Lymphoma Kinase (ALK) Tests
EGFR Mutation Tests
KRAS Test
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Tumor Biomarker Test for each application, including
Lung cancer
Breast cancer
Colorectal
Prostate Cancer
Blood Cancer

If you have any special requirements, please let us know and we will offer you the report as you want.


Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Tumor Biomarker Test Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Prostate Specific Antigen Tests Market Performance (Volume)
      • 2.1.2 CTC Tests Market Performance (Volume)
      • 2.1.3 Alpha-Fetoprotein (AFP) Tests Market Performance (Volume)
      • 2.1.4 CA Test Market Performance (Volume)
      • 2.1.5 HER2 Tests Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Prostate Specific Antigen Tests Market Performance (Value)
      • 2.1.2 CTC Tests Market Performance (Value)
      • 2.1.3 Alpha-Fetoprotein (AFP) Tests Market Performance (Value)
      • 2.1.4 CA Test Market Performance (Value)
      • 2.1.5 HER2 Tests Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Lung cancer Market Performance (Volume)
      • 3.1.2 Breast cancer Market Performance (Volume)
      • 3.1.3 Colorectal Market Performance (Volume)
      • 3.1.4 Prostate Cancer Market Performance (Volume)
      • 3.1.5 Blood Cancer Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Abbott Laboratories, Inc.
      • 4.1.1 Abbott Laboratories, Inc. Profiles
      • 4.1.2 Abbott Laboratories, Inc. Product Information
      • 4.1.3 Abbott Laboratories, Inc. Tumor Biomarker Test Business Performance
      • 4.1.4 Abbott Laboratories, Inc. Tumor Biomarker Test Business Development and Market Status
    • 4.2 Agilent Technologies
      • 4.2.1 Agilent Technologies Profiles
      • 4.2.2 Agilent Technologies Product Information
      • 4.2.3 Agilent Technologies Tumor Biomarker Test Business Performance
      • 4.2.4 Agilent Technologies Tumor Biomarker Test Business Development and Market Status
    • 4.3 AstraZeneca
      • 4.3.1 AstraZeneca Profiles
      • 4.3.2 AstraZeneca Product Information
      • 4.3.3 AstraZeneca Tumor Biomarker Test Business Performance
      • 4.3.4 AstraZeneca Tumor Biomarker Test Business Development and Market Status
    • 4.4 Becton Dickinson & Co.
      • 4.4.1 Becton Dickinson & Co. Profiles
      • 4.4.2 Becton Dickinson & Co. Product Information
      • 4.4.3 Becton Dickinson & Co. Tumor Biomarker Test Business Performance
      • 4.4.4 Becton Dickinson & Co. Tumor Biomarker Test Business Development and Market Status
    • 4.5 Biocept Inc.
      • 4.5.1 Biocept Inc. Profiles
      • 4.5.2 Biocept Inc. Product Information
      • 4.5.3 Biocept Inc. Tumor Biomarker Test Business Performance
      • 4.5.4 Biocept Inc. Tumor Biomarker Test Business Development and Market Status
    • 4.6 Cancer Genetics Inc.
      • 4.6.1 Cancer Genetics Inc. Profiles
      • 4.6.2 Cancer Genetics Inc. Product Information
      • 4.6.3 Cancer Genetics Inc. Tumor Biomarker Test Business Performance
      • 4.6.4 Cancer Genetics Inc. Tumor Biomarker Test Business Development and Market Status
    • 4.7 Danaher Corporation
      • 4.7.1 Danaher Corporation Profiles
      • 4.7.2 Danaher Corporation Product Information
      • 4.7.3 Danaher Corporation Tumor Biomarker Test Business Performance
      • 4.7.4 Danaher Corporation Tumor Biomarker Test Business Development and Market Status
    • 4.8 Foundation Medicine Inc.
      • 4.8.1 Foundation Medicine Inc. Profiles
      • 4.8.2 Foundation Medicine Inc. Product Information
      • 4.8.3 Foundation Medicine Inc. Tumor Biomarker Test Business Performance
      • 4.8.4 Foundation Medicine Inc. Tumor Biomarker Test Business Development and Market Status
    • 4.9 Illumina Inc.
      • 4.9.1 Illumina Inc. Profiles
      • 4.9.2 Illumina Inc. Product Information
      • 4.9.3 Illumina Inc. Tumor Biomarker Test Business Performance
      • 4.9.4 Illumina Inc. Tumor Biomarker Test Business Development and Market Status
    • 4.10 LabCorp Of America Holdings
      • 4.10.1 LabCorp Of America Holdings Profiles
      • 4.10.2 LabCorp Of America Holdings Product Information
      • 4.10.3 LabCorp Of America Holdings Tumor Biomarker Test Business Performance
      • 4.10.4 LabCorp Of America Holdings Tumor Biomarker Test Business Development and Market Status
    • 4.11 Luminex Corporation
    • 4.12 Myriad Genetics Inc.
    • 4.13 AstraZeneca

    5 Market Performance for Manufacturers

    • 5.1 China Tumor Biomarker Test Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 China Tumor Biomarker Test Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 China Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 China Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 South China Market Performance for Manufacturers
      • 6.1.1 South China Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 South China Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 South China Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 South China Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 East China Market Performance for Manufacturers
      • 6.2.1 East China Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 East China Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 East China Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 East China Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 Southwest China Market Performance for Manufacturers
      • 6.3.1 Southwest China Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 Southwest China Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 Southwest China Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 Southwest China Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 Northeast China Market Performance for Manufacturers
      • 6.4.1 Northeast China Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 Northeast China Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 Northeast China Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 Northeast China Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration
    • 6.5 North China Market Performance for Manufacturers
      • 6.5.1 North China Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.5.2 North China Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.5.3 North China Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
      • 6.5.4 North China Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
      • 6.5.5 Market Concentration
    • 6.6 Central China Market Performance for Manufacturers
      • 6.6.1 Central China Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.6.2 Central China Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.6.3 Central China Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
      • 6.6.4 Central China Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
      • 6.6.5 Market Concentration
    • 6.7 Northwest China Market Performance for Manufacturers
      • 6.7.1 Northwest China Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.7.2 Northwest China Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.7.3 Northwest China Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
      • 6.7.4 Northwest China Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
      • 6.7.5 Market Concentration

    7 China Tumor Biomarker Test Market Performance (Sales Point)

    • 7.1 China Tumor Biomarker Test Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 China Tumor Biomarker Test Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 China Tumor Biomarker Test Price (USD/Unit) by Regions 2013-2018
    • 7.4 China Tumor Biomarker Test Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 China Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 South China Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 East China Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 Southwest China Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 Northeast China Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.6 North China Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.7 Central China Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Northwest China Tumor Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Lung cancer Industry
    • 11.2 Breast cancer Industry
    • 11.3 Colorectal Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 China Tumor Biomarker Test Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 China Tumor Biomarker Test Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 South China Tumor Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 East China Tumor Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 Southwest China Tumor Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 Northeast China Tumor Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 North China Tumor Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Central China Tumor Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Northwest China Tumor Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Prostate Specific Antigen Tests Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 CTC Tests Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.4 Alpha-Fetoprotein (AFP) Tests Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.5 CA Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Lung cancer Sales and and Growth Rate 2019-2024
      • 12.4.3 Breast cancer Sales and and Growth Rate 2019-2024
      • 12.4.4 Colorectal Sales and and Growth Rate 2019-2024
      • 12.4.5 Prostate Cancer Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 China Tumor Biomarker Test Price (USD/Unit) Trend 2019-2024
      • 12.5.2 China Tumor Biomarker Test Gross Profit Trend 2019-2024

    13 Conclusion

    Summary:
    Get latest Market Research Reports on Tumor Biomarker Test. Industry analysis & Market Report on Tumor Biomarker Test is a syndicated market report, published as China Tumor Biomarker Test Market Report 2018. It is complete Research Study and Industry Analysis of Tumor Biomarker Test market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,000.00
    		$5,800.00
    		2,313.00
    		4,471.80
    		2,778.00
    		5,370.80
    		459,720.00
    		888,792.00
    		252,990.00
    		489,114.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo